Market access and affordability
Clarify budget impact, adoption scenarios, payer implications, and value arguments before a launch or policy discussion.
Pharmacoeconomic Services
We help healthcare teams design evidence studies, model economic impact, analyse real-world data, and package findings for market access, policy, advisory, and internal strategy decisions.

What this helps with
Clarify budget impact, adoption scenarios, payer implications, and value arguments before a launch or policy discussion.
Plan the right study design, protocol, data source, and analysis approach for a clear evidence-generation pathway.
Structure advisory boards, Delphi studies, and consensus meetings so expert input becomes usable evidence.
Service scope
Keep the work under one engagement, then combine the right modules depending on the decision you need to support.
Define the population, comparator, evidence gap, endpoints, stakeholder needs, and decision context.
Develop the study protocol, analytical workflow, economic model, assumptions, and scenario structure.
Translate findings into clear reports, tables, slide-ready visuals, and decision narratives for stakeholders.
Epidemiological & Database
Design and analysis of observational studies using real-world datasets, registries, patient cohorts, and epidemiological evidence.
Market Access
Budget impact models that estimate affordability, adoption scenarios, resource implications, and payer-level financial outcomes.
Health Technology Assessment
Economic models that compare interventions through costs, outcomes, assumptions, sensitivity analysis, and decision-ready outputs.
Consensus Development
Structured expert engagement including advisory boards, Delphi panels, consensus meetings, synthesis, and reporting.
Data Interpretation
Statistical planning, data cleaning, model selection, subgroup analysis, validation, visualization, and publication-ready tables.
Research Planning
Study objectives, endpoints, methodology, analysis plans, protocol writing, timelines, and evidence-generation roadmaps.
Expected outputs
The goal is not only to analyse data. It is to make the evidence usable for decision-makers, commercial teams, clinical experts, policy audiences, and internal leadership.
Study concept note, protocol, and analysis plan
Real-world evidence and epidemiological analysis report
Budget impact or cost-effectiveness model outputs
Consensus meeting, Delphi, or advisory board report
Statistical tables, visual summaries, and interpretation notes
Database setup, reporting workflow, and dashboard-ready outputs